ENFLURANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Enflurane, and when can generic versions of Enflurane launch?
Enflurane is a drug marketed by Abbott and Piramal Critical and is included in two NDAs.
The generic ingredient in ENFLURANE is enflurane. There is one drug master file entry for this compound. Additional details are available on the enflurane profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ENFLURANE?
- What are the global sales for ENFLURANE?
- What is Average Wholesale Price for ENFLURANE?
Summary for ENFLURANE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 3 |
| DailyMed Link: | ENFLURANE at DailyMed |
Recent Clinical Trials for ENFLURANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Penn State University | Phase 4 |
| University of Leipzig | Phase 4 |
| RWTH Aachen University | Phase 4 |
Medical Subject Heading (MeSH) Categories for ENFLURANE
Anatomical Therapeutic Chemical (ATC) Classes for ENFLURANE
US Patents and Regulatory Information for ENFLURANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | ENFLURANE | enflurane | LIQUID;INHALATION | 070803-001 | Sep 8, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Piramal Critical | ENFLURANE | enflurane | LIQUID;INHALATION | 074396-001 | Jul 29, 1994 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
